Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Astria Therapeutics, Inc. (ATXS) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.71M |
|
$-31.64M |
|
-- |
|
$0.71M |
|
$34.81M |
|
$-34.10M |
|
$2.46M |
|
$-31.64M |
|
$-31.64M |
|
$-31.64M |
|
$-31.64M |
|
$-31.64M |
|
$-31.64M |
|
$-34.10M |
|
$-34.10M |
|
58.01M |
|
58.01M |
|
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$253.55M |
|
-- |
|
$18.32M |
|
$271.87M |
|
$23.52M |
|
-- |
|
$110.42M |
|
$133.94M |
|
$137.93M |
|
$137.93M |
|
$137.93M |
|
56.43M |
|
| Cash Flow Statement Financials | |
$-102.37M |
|
$138.83M |
|
$0.00M |
|
$59.82M |
|
$96.28M |
|
$36.46M |
|
$12.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.78 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-4830.60% |
|
-4830.60% |
|
-- |
|
-4482.01% |
|
-4482.01% |
|
$-102.96M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.04 |
|
2198.12 |
|
-22.94% |
|
-22.94% |
|
-11.64% |
|
-22.94% |
|
$2.44 |
|
$-1.77 |
|
$-1.76 |
|